Literature DB >> 29229718

Smoking is the first cause of morbidity and death in psychiatric settings.

Alain Braillon1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29229718      PMCID： PMC5718897          DOI： 10.1503/cmaj.733483

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  The effect of stopping smoking on perceived stress levels.

Authors:  Peter Hajek; Tamara Taylor; Hayden McRobbie
Journal:  Addiction       Date:  2010-06-07       Impact factor: 6.526

2.  Smoke-free policies in psychiatric hospitals need resources.

Authors:  Suzanne H Gage; Olivia M Maynard
Journal:  Lancet Psychiatry       Date:  2017-06-15       Impact factor: 27.083

Review 3.  Implementation of smoking cessation treatment in substance use disorder treatment settings: a review.

Authors:  Hannah K Knudsen
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-17       Impact factor: 3.829

4.  Trends in standardized mortality among individuals with schizophrenia, 1993-2012: a population-based, repeated cross-sectional study.

Authors:  Evgenia Gatov; Laura Rosella; Maria Chiu; Paul A Kurdyak
Journal:  CMAJ       Date:  2017-09-18       Impact factor: 8.262

5.  Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.

Authors:  Michael H Allen; Martin Debanné; Coralie Lazignac; Eric Adam; L Miriam Dickinson; Cristian Damsa
Journal:  Am J Psychiatry       Date:  2011-01-18       Impact factor: 18.112

6.  Premature Mortality Among Adults With Schizophrenia in the United States.

Authors:  Mark Olfson; Tobias Gerhard; Cecilia Huang; Stephen Crystal; T Scott Stroup
Journal:  JAMA Psychiatry       Date:  2015-12       Impact factor: 21.596

7.  Effect of implementation of a smoke-free policy on physical violence in a psychiatric inpatient setting: an interrupted time series analysis.

Authors:  Debbie Robson; Gilda Spaducci; Ann McNeill; Duncan Stewart; Tom J K Craig; Mary Yates; Lisa Szatkowski
Journal:  Lancet Psychiatry       Date:  2017-06-14       Impact factor: 27.083

8.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.

Authors:  Robert M Anthenelli; Neal L Benowitz; Robert West; Lisa St Aubin; Thomas McRae; David Lawrence; John Ascher; Cristina Russ; Alok Krishen; A Eden Evins
Journal:  Lancet       Date:  2016-04-22       Impact factor: 79.321
  8 in total
  1 in total

1.  A retrospective study of smoking cessation intervention among university students.

Authors:  Yong Yang; Ge Jin; Li-Yan Yao; Ying-Ying Niu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.